Isomab Ltd
PrivateLast Round
Seed
Feb 20, 2024
Total Funding Raised
$10.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Isomab Ltd is a biotechnology company that develops isoform-specific antibody therapies for the treatment of cardiovascular and peripheral ischemic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isomab Ltd Comparables
Compare Isomab Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai CirCode Biomed Co. Ltd. | 71% | |
| Ambulero, Inc. | 71% | |
| advanceCOR | 70% |
Isomab Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 20, 2024 |
Isomab Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SCVC | Seed |
| Mercia Ventures | Seed |
| Science Creates Ventures | Seed |
| Broadview Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 33% QoQ from 12 to 16 employees.
- May 19, 2026
Monthly visitors grew 221% MoM.
Recent news
Latest coverage and updates
- attends_eventSep 2, 2026
Isomab attended event ESC Congress 2026 on Sep 2nd '26.
- attends_eventAug 30, 2026
Isomab attended event European Society of Cardiology Congress 2026 on Aug 30th '26.
Isomab Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Isomab Ltd's valuation, stock price, and market status.
Is Isomab Ltd a public or private company?
Isomab Ltd is a private company.
What is the current stock price of Isomab Ltd?
Isomab Ltd is a private company with no public stock price. No recent secondary market data is available.
How much is Isomab Ltd worth (valuation)?
Valuation information for Isomab Ltd is not publicly available.
Can I buy Isomab Ltd stock?
Isomab Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Isomab Ltd's last funding round?
Isomab Ltd's most recent funding round was Seed on February 20, 2024.
Who are the main investors in Isomab Ltd?
Key investors in Isomab Ltd include Broadview Ventures.
Will Isomab Ltd IPO soon?
No public IPO plans have been announced for Isomab Ltd.
How can I track Isomab Ltd secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Isomab Ltd's secondary market activity and sign up for updates.